Allspring Global Investments Holdings, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,743
-99.8%
4,424
-99.6%
0.00%
-100.0%
Q2 2023$28,634,746
-42.2%
1,131,361
-26.4%
0.05%
-43.9%
Q1 2023$49,514,822
+145.1%
1,537,250
+40.4%
0.08%
+141.2%
Q4 2022$20,204,912
+27.7%
1,094,524
+86.7%
0.03%
+21.4%
Q3 2022$15,828,000
+316460.0%
586,275
+151392.2%
0.03%
Q2 2022$5,000
-87.2%
387
-80.7%
0.00%
Q1 2022$39,000
+30.0%
2,005
+6.9%
0.00%
Q4 2021$30,0001,8750.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders